Mechanism of cholesterol-assisted oligomeric channel formation by a short Alzheimer β-amyloid peptide

Journal of Neurochemistry

Volumn 128, Issue 1, 2014, Pages 186-195

  Di Scala, Coralie ^a   Troadec, Jean Denis ^a   Lelièvre, Clément ^a   Garmy, Nicolas ^a   Fantini, Jacques ^a   Chahinian, Henri ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Alzheimer peptide; amyloid pore; calcium channel; neurotoxicity; oligomer

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[22-35]; CALCIUM ION; CHOLESTEROL; ION CHANNEL; OLIGOMER; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ALPHA HELIX; ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CHEMICAL BINDING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROGEN BOND; MOLECULAR DYNAMICS; OLIGOMERIZATION; PRIORITY JOURNAL;

ALZHEIMER PEPTIDE; AMYLOID PORE; CALCIUM CHANNEL; NEUROTOXICITY; OLIGOMER;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELL LINE, TUMOR; CHOLESTEROL; HUMANS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84890805527     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12390     Document Type: Article

References (45)

1. Abramov A. Y., Canevari L., and, Duchen M. R., (2003) Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J. Neurosci. 23, 5088-5095. (Pubitemid 36793236)
2. Abramov A. Y., Ionov M., Pavlov E., and, Duchen M. R., (2011) Membrane cholesterol content plays a key role in the neurotoxicity of β-amyloid: implications for Alzheimer's disease. Aging Cell 10, 595-603.
3. Arispe N., and, Doh M., (2002) Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J. 16, 1526-1536. (Pubitemid 35154635)
4. Arispe N., Rojas E., and, Pollard H. B., (1993) Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl Acad. Sci. USA 90, 567-571. (Pubitemid 23028904)
5. Arispe N., Pollard H. B., and, Rojas E., (1996) Zn2 + interaction with Alzheimer amyloid beta protein calcium channels. Proc. Natl Acad. Sci. USA 93, 1710-1715.
6. Arispe N., Diaz J., Durell S. R., Shafrir Y., and, Guy H. R., (2010) Polyhistidine peptide inhibitor of the Abeta calcium channel potently blocks the Abeta-induced calcium response in cells. Theoretical modeling suggests a cooperative binding process. Biochemistry 49, 7847-7853.
7. Ashley R. H., Harroun T. A., Hauss T., Breen K. C., and, Bradshaw J. P., (2006) Autoinsertion of soluble oligomers of Alzheimer's Abeta(1-42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface. BMC Struct. Biol. 6, 21.
8. Avdulov N. A., Chochina S. V., Igbavboa U., Warden C. S., Vassiliev A. V., and, Wood W. G., (1997) Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J. Neurochem. 69, 1746-1752. (Pubitemid 27406976)
9. Barrett P. J., Song Y., Van Horn W. D., Hustedt E. J., Schafer J. M., Hadziselimovic A., Beel A. J., and, Sanders C. R., (2012) The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336, 1168-1171.
10. Beel A. J., Sakakura M., Barrett P. J., and, Sanders C. R., (2010) Direct binding of cholesterol to the amyloid precursor protein: an important interaction in lipid-Alzheimer's disease relationships? Biochim. Biophys. Acta 1801, 975-982.
11. Crowet J. M., Lins L., Dupiereux I., Elmoualija B., Lorin A., Charloteaux B., Stroobant V., Heinen E., and, Brasseur R., (2007) Tilted properties of the 67-78 fragment of alpha-synuclein are responsible for membrane destabilization and neurotoxicity. Proteins 68, 936-947. (Pubitemid 47434715)
12. Di Scala C., Yahi N., Lelièvre C., Garmy N., Chahinian H., and, Fantini J., (2013) Biochemical identification of a linear cholesterol-binding domain within Alzheimer's beta amyloid peptide. ACS Chem. Neurosci. 4, 509-517.
13. Ehehalt R., Keller P., Haass C., Thiele C., and, Simons K., (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113-123. (Pubitemid 36091721)
14. Esparza T. J., Zhao H., Cirrito J. R., Cairns N. J., Bateman R. J., Holtzman D. M., and, Brody D. L., (2012) Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls. Ann. Neurol. 73, 104-119.
15. Fändrich M., (2012) Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity. J. Mol. Biol. 421, 427-440.
16. Fantini J., and, Barrantes F. J., (2013) How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains. Front. Physiol. 4, 31.
17. Fantini J., and, Yahi N., (2010) Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases. Expert Rev. Mol. Med. 12, e27.
18. Fantini J., and, Yahi N., (2011) Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. J. Mol. Biol. 408, 654-669.
19. Fantini J., Carlus D., and, Yahi N., (2011) The fusogenic tilted peptide (67-78) of α-synuclein is a cholesterol binding domain. Biochim. Biophys. Acta 1808, 2343-2351.
20. Fraser P. E., Duffy L. K., O'Malley M. B., Nguyen J., Inouye H., and, Kirschner D. A., (1991) Morphology and antibody recognition of synthetic beta-amyloid peptides. J. Neurosci. Res. 28, 474-485.
21. Gleason N. J., Vostrikov V. V., Greathouse D. V., and, Koeppe R. E. II, (2013) Buried lysine, but not arginine, titrates and alters transmembrane helix tilt. Proc. Natl Acad. Sci. USA 110, 1692-1695.
22. Harris J. R., (2008) Cholesterol binding to amyloid-beta fibrils: a TEM study. Micron 39, 1192-1196.
23. Hartmann T., (2001) Cholesterol, A beta and Alzheimer's disease. Trends Neurosci. 24, S45-S48.
24. Jang H., Arce F. T., Ramachandran S., Capone R., Azimova R., Kagan B. L., Nussinov R., and, Lal R., (2010) Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's disease and Down syndrome. Proc. Natl Acad. Sci. USA 107, 6538-6543.
25. Ji S. R., Wu Y., and, Sui S. F., (2002) Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation. J. Biol. Chem. 277, 6273-6279. (Pubitemid 34975653)
26. Lahdo R., and, De La Fournière-Bessueille L., (2004) Insertion of the amyloid precursor protein into lipid monolayers: effects of cholesterol and apolipoprotein E. Biochem. J. 382, 987-994. (Pubitemid 39312914)
27. Lal R., Lin H., and, Quist A. P., (2007) Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. Biochim. Biophys. Acta 1768, 1966-1975. (Pubitemid 47125855)
28. Levitan I., Fang Y., Rosenhouse-Dantsker A., and, Romanenko V., (2010) Cholesterol and ion channels. Subcell. Biochem. 51, 509-549.
29. Lukiw W. J., (2013) Alzheimer's disease (AD) as a disorder of the plasma membrane. Front. Physiol. 4, 24.
30. Plotnikov A. N., Schlessinger J., Hubbard S. R., and, Mohammadi M., (1999) Structural basis for FGF receptor dimerization and activation. Cell 98, 641-650. (Pubitemid 29418955)
31. Qiu L., Lewis A., Como J., Vaughn M. W., Huang J., Somerharju P., Virtanen J., and, Cheng K. H., (2009) Cholesterol modulates the interaction of beta-amyloid peptide with lipid bilayers. Biophys. J. 96, 4299-4307.
32. Quist A., Doudevski I., Lin H., Azimova R., Ng D., Frangione B., Kagan B., Ghiso J., and, Lal R., (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl Acad. Sci. USA 102, 10427-10432. (Pubitemid 41061570)
33. Shankar G. M., Li S., Mehta T. H., et al,. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842.
34. Simmons M. A., and, Schneider C. R., (1993) Amyloid beta peptides act directly on single neurons. Neurosci. Lett. 150, 133-136. (Pubitemid 23153670)
35. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C. G., and, Simons K., (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA 95, 6460-6464. (Pubitemid 28249035)
36. Singh R. P., Brooks B. R., and, Klauda J. B., (2009) Binding and release of cholesterol in the Osh4 protein of yeast. Proteins 75, 468-477.
37. Strandberg E., and, Killian J. A., (2003) Snorkeling of lysine side chains in transmembrane helices: how easy can it get? FEBS Lett. 544, 69-73. (Pubitemid 36628038)
38. Takadera T., Sakura N., Mohri T., and, Hashimoto T., (1993) Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention. Neurosci. Lett. 161, 41-44. (Pubitemid 23311060)
39. Thakur G., Micic M., and, Leblanc R. M., (2009) Surface chemistry of Alzheimer's disease: a Langmuir monolayer approach. Colloids Surf. B Biointerfaces 74, 436-456.
40. Thomsen R., and, Christensen M. H., (2006) MolDock: a new technique for high-accuracy molecular docking. J. Med. Chem. 49, 3315-3321. (Pubitemid 43830529)
41. Trikha S., and, Jeremic A. M., (2011) Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol. J. Biol. Chem. 286, 36086-36097.
42. Wang J., Ohno-Matsui K., and, Morita I., (2012) Cholesterol enhances amyloid β deposition in mouse retina by modulating the activities of Aβ-regulating enzymes in retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 424, 704-709.
43. Yu X., and, Zheng J., (2012) Cholesterol promotes the interaction of Alzheimer β-amyloid monomer with lipid bilayer. J. Mol. Biol. 421, 561-571.
44. Zhao B. Q., Guo Y. R., Li X. L., Zang T., Qu H. Y., Zhou J. P., Li Q., and, Sun M. J., (2011) Amelioration of dementia induced by Aβ 22-35 through rectal delivery of undecapeptide-hEGF to mouse brain. Int. J. Pharm. 405, 1-8.
45. Zhorov B. S., and, Ananthanarayanan V. S., (1996) Structural model of a synthetic Ca2 + channel with bound Ca2 + ions and dihydropyridine ligand. Biophys. J. 70, 22-37.